The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
Abroad (travel likely)RecruitingPHASE2
Conditions
Advanced Cancer · Solid Tumor · Haematological Malignancy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Turku University Hospital Cancer Centre, Turku, Southwest Finland, Finland
Contact: Study coordinator (Erika Alanne, MD, PhD)Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Uusimaa, Finland
Contact: Study coordinator (Tanja Juslin)Contact: Principal Investigator (Katriina Jalkanen, MD, PhD)Kuopio University Hospital, Kuopio, Finland
Contact: Study coordinator (Okko Kääriäinen, MD)Oulu University Hospital OYS Cancer Center, Oulu, Finland
Contact: Study coordinator (Sanna Iivanainen, MD. PhD.)Tampere University Hospital Department of Oncology, Tampere, Finland
Contact: Study coordinator (Minna Tanner, MD, PhD)
Study leads
Katriina Jalkanen, MD, PhD
Principal Investigator
Helsinki University Hospital Comprehensive Cancer Centre